These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
485 related items for PubMed ID: 22736024
1. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway. Liang L, Li L, Zeng J, Gao Y, Chen YL, Wang ZQ, Wang XY, Chang LS, He D. Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024 [Abstract] [Full Text] [Related]
2. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Chang HR, Chen PN, Yang SF, Sun YS, Wu SW, Hung TW, Lian JD, Chu SC, Hsieh YS. Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189 [Abstract] [Full Text] [Related]
3. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway. Tsai PC, Hsieh CY, Chiu CC, Wang CK, Chang LS, Lin SR. Toxicon; 2012 Oct; 60(5):734-43. PubMed ID: 22683533 [Abstract] [Full Text] [Related]
4. Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Kim S, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE. Anticancer Res; 2011 Nov; 31(11):3767-73. PubMed ID: 22110198 [Abstract] [Full Text] [Related]
5. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chun J, Kim YS. Chem Biol Interact; 2013 Oct 05; 205(3):212-21. PubMed ID: 23867902 [Abstract] [Full Text] [Related]
6. Autophagy induction by silibinin positively contributes to its anti-metastatic capacity via AMPK/mTOR pathway in renal cell carcinoma. Li F, Ma Z, Guan Z, Chen Y, Wu K, Guo P, Wang X, He D, Zeng J. Int J Mol Sci; 2015 Apr 15; 16(4):8415-29. PubMed ID: 25884331 [Abstract] [Full Text] [Related]
7. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS. Oncol Rep; 2012 Nov 15; 28(5):1799-807. PubMed ID: 22923287 [Abstract] [Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Farabegoli F, Papi A, Orlandi M. Biosci Rep; 2011 Apr 15; 31(2):99-108. PubMed ID: 20446926 [Abstract] [Full Text] [Related]
9. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, Wan XX, He QY, Li JH, Qu JQ, Chen Y, Xiao ZQ. J Cell Biochem; 2011 Sep 15; 112(9):2508-17. PubMed ID: 21557297 [Abstract] [Full Text] [Related]
10. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Hsieh YS, Chu SC, Yang SF, Chen PN, Liu YC, Lu KH. Carcinogenesis; 2007 May 15; 28(5):977-87. PubMed ID: 17116726 [Abstract] [Full Text] [Related]
11. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Dong QZ, Wang Y, Tang ZP, Fu L, Li QC, Wang ED, Wang EH. Am J Pathol; 2013 Mar 15; 182(3):954-64. PubMed ID: 23306155 [Abstract] [Full Text] [Related]
12. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma. Li L, Gao Y, Zhang L, Zeng J, He D, Sun Y. Cancer Lett; 2008 Dec 08; 272(1):61-9. PubMed ID: 18723275 [Abstract] [Full Text] [Related]
13. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways. Ho CC, Lai KC, Hsu SC, Kuo CL, Ma CY, Lin ML, Yang JS, Chung JG. Hum Exp Toxicol; 2011 Apr 08; 30(4):296-306. PubMed ID: 20498032 [Abstract] [Full Text] [Related]
14. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ. Cancer Res; 2003 Jun 01; 63(11):2940-7. PubMed ID: 12782601 [Abstract] [Full Text] [Related]
15. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling. Chen HJ, Lin CM, Lee CY, Shih NC, Amagaya S, Lin YC, Yang JS. Int J Oncol; 2013 Aug 01; 43(2):629-37. PubMed ID: 23754208 [Abstract] [Full Text] [Related]
16. Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC, Lee IS. Biochem Biophys Res Commun; 2007 Mar 02; 354(1):165-71. PubMed ID: 17214970 [Abstract] [Full Text] [Related]
17. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Chu SC, Chiou HL, Chen PN, Yang SF, Hsieh YS. Mol Carcinog; 2004 Jul 02; 40(3):143-9. PubMed ID: 15224346 [Abstract] [Full Text] [Related]
18. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression. Ahmad N, Gali H, Javed S, Agarwal R. Biochem Biophys Res Commun; 1998 Jun 18; 247(2):294-301. PubMed ID: 9642119 [Abstract] [Full Text] [Related]
19. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L. Mol Cancer Res; 2011 Feb 18; 9(2):161-72. PubMed ID: 21205837 [Abstract] [Full Text] [Related]
20. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y. Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]